Division of Hepato-Bilio-Pancreatic Surgery was established in 2001. In the early 1980 s, institute for biliary surgery established by Prof Li Qian, predecessor of this division. Abdominal Surgery compiled by the Professor Qian Li is China's first monograph published in abdominal surgery, and it has influenced several generations of domestic surgeons. In 1992, we performed the first laparoscopic cholecystectomy in Southern Zhejiang. From 2001, we started to perform the solo liver, simultaneous liver-kidney and pancrease-kidney transplantation. Our Academic Leader, Prof Qiyu Zhang, did practice and studied theory following his tutor surgery mogul Li Qian. He specializes in the diagnosis and treatment of abdominal surgical diseases.Currently, he serves as Vice-Chairman of Surgery Committee of Zhejiang Province, Vice-Chairman of Chinese Anti-Cancer Association of Zhejiang Province, Chairman of Surgery Committee of Wenzhou, Principal of Zhejiang Extremely Key Subject of Surgery, Associate Editor-In-Chief of Journal of Hepatopancreatobiliary Surg. Our division has 145 fixed beds, 31 doctors including 14 with senior titles, 10 with PhD and 15 with Master's degree. We also undertake scientific research of 5 projects of national and 18 provincial level. We have published dozens of research articles in reputable academic journals, such as Plos One, Pancreas, Pancreatology and Journal of Gastroenterology and Hepatology. Moreover, we carried out several modified surgical techniques.
(1)Selective decongestive devascularization shunt of gastrosplenic region for portal hypertension treatment. This novel surgical option is first proposed and created by us. The operation can maintain the hepatic portal vein blood perfusion to liver and increases hepatic arterial blood flow. So it can remit hypersplenism, reduce portal pressure of spleen-stomach area. Moreover, it can keep the blood perfusion to liver from mesenteric area, retain partial spleen immune function, and prevent esophageal variceal bleeding complicated by portal hypertension at the same time. It is a technical breakthrough for hypertension surgical treatment.
(2)Early intensive resuscitation for severe acute pancreatitis. Early regional arterial infusion therapy for severe acute pancreatitis, coordinating with the recovery of bowel function, respiratory support, nutritional support and other measures are earliest carried out by our division in Southern Zhejiang. It has many advantages, such as symptoms and signs of relief fast, especially more significant improvement in abdominal pain, early recovery of gastrointestinal function, blood and urine amylase reduction quickly to normal, low complication rate, high cure rate , shorter hospital stay, low hospital costs.
(3)New surgical treatment concept for pancreatic neoplasm. We further normalize and standardize the surgical treatment for pancreatic cancer, in strict accordance with guidelines for the management of pancreatic cancer issued by the Ministry of Health. We strive for minimally invasive surgical approach for benign pancreatic neoplasm and other benign diseases. We actively carry out many surgical approaches, which can preserve organ function, such as pancreatectomy preserving the spleen and splenic vessels for pancreatic body and tail neoplasm, medial pancreatectomy, local resection of pancreatic neoplasm, laparoscopic drainage of pancreatic pseudocysts and local surgical resection of neoplasm of the duodenal papilla.
(4)Comprehensive treatment for primary liver cancer. Provide a comprehensive preoperative examination and assessment for patients. Identify feasible methods for treatment. Blood loss and surgical risk are significantly reduced using bloodless liver resection and hepatic resections under low central venous pressure anesthesia. We have routinely carried out right hepatic trisegmentectomy, right hepatectomy, left hepatectomy, left hepatectomy with resection of the caudate lobe and resection of Segment 8. Interventional therapy, radiofrequency ablation, targeted therapy and system treatment technology have been used routinely for liver cancer therapy.
(5)Various therapy methods are applied to biliary tract disease. We have adopted several different methods for cholelithiasis and biliary tract infection treatment. In addition to conventional biliary tract surgery, we have carried out laparoscopic surgery, percutaneous endoscopic treatment of biliary diseases, percutaneous transhepaticcholangial drainage and percutaneous transhepatic gallbladder drainage. We routinely carried out resection of complicated hepatic hilar bile duct carcinoma and radical resection of carcinoma of the gallbladder. We actively carried out cysts excision instead of internal and external drainage for choledochal cysts.
(6)Specification, innovation and improvement of gastrointestinal tumor surgery. Our division not only carried out specialist surgery for Hepato-Biliary-Pancreatic and splenic surgery, but also actively carried out standardized surgical treatment for the digestive tract tumors, such as the gastric cancer, small intestine cancer, colon cancer, rectal cancer, including the complete mesocolic excision and total mesorectal excision. We have pioneered many innovative operations for gastric cancer therapy in region of Southern Zhejiang, such as continual jejunal interposition of esophagoduodenostomy after total gastrectomy and continual jejunal interposition of stomach and dodecadactylon after proximal gastrectomy. Moreover, we carried out the first anastomosis without hemostasis in the submucosa layer for gastrointestinal tracts and actively carried out local resection of huge duodenum stromal tumor. Additionally, our division was granted “Points awarded doctorate” in 2007 and gained the “Zhejiang Extremely Key Subject of Surgery” in 2008. Overall, we use the first-rate facilities and offer outstanding diagnostic services and treatments. We are committed to provide first-class medical services for patients. Your health is our greatest wish!